| 000 | 01689 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517221629.0 | ||
| 264 | 0 | _c20190102 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/s12936-018-2367-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLover, Andrew A | |
| 245 | 0 | 0 |
_aPrevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals. _h[electronic resource] |
| 260 |
_bMalaria journal _cJun 2018 |
||
| 300 |
_a218 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAsymptomatic Infections _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aCommunicable Disease Control |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlucosephosphate Dehydrogenase Deficiency _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaos _xepidemiology |
| 650 | 0 | 4 |
_aMalaria _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDantzer, Emily | |
| 700 | 1 | _aHongvanthong, Bouasy | |
| 700 | 1 | _aChindavongsa, Keobouphaphone | |
| 700 | 1 | _aWelty, Susie | |
| 700 | 1 | _aReza, Tania | |
| 700 | 1 | _aKhim, Nimol | |
| 700 | 1 | _aMenard, Didier | |
| 700 | 1 | _aBennett, Adam | |
| 773 | 0 |
_tMalaria journal _gvol. 17 _gno. 1 _gp. 218 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-018-2367-5 _zAvailable from publisher's website |
| 999 |
_c28487684 _d28487684 |
||